title: Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron.
authors.forename: K
authors.initials: K
authors.lastname: Nagai
authors.forename: T
authors.initials: T
authors.lastname: Shimizu
authors.forename: A
authors.initials: A
authors.lastname: Togo
authors.forename: M
authors.initials: M
authors.lastname: Takeya
authors.forename: Y
authors.initials: Y
authors.lastname: Yokomizo
authors.forename: Y
authors.initials: Y
authors.lastname: Sakata
authors.forename: T
authors.initials: T
authors.lastname: Matsuishi
authors.forename: H
authors.initials: H
authors.lastname: Kato
mesh_terms: D000927:Anticonvulsants / Q000097:blood*; D002648:Child; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D013845:Thienamycins / Q000494:pharmacology; D014635:Valproic Acid / Q000097:blood*; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D000927:Anticonvulsants; D013845:Thienamycins; D015091:beta-Alanine; C075316:panipenem-betamipron; D014635:Valproic Acid